GlassScriptPhysician profile
Joseph Kevin Pidkowicz
NPI 1659488955
$2,808.47
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,010 · 2020: $313 · 2021: $887 · 2022: $598.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $857.64 | 2019-2022 | |
| Lilly USA, LLC | $397.32 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $236.43 | 2019-2021 | |
| Amgen INC. | $185.91 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $181.27 | 2019-2022 | |
| Genzyme Corporation | $147.83 | 2019-2022 | |
| Ucb, INC. | $120.24 | 2019-2021 | |
| Leo Pharma INC. | $120.23 | 2021-2022 | |
| Dermira, INC. | $96.70 | 2019 | |
| Galderma Laboratories, L.P. | $84.38 | 2019-2022 | |
| Incyte Corporation | $71.44 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $49.72 | 2019-2020 | |
| Prugen, INC. Pharmaceuticals | $48.29 | 2020 | |
| Sanofi-Aventis U.S. LLC | $44.42 | 2019-2021 | |
| Janssen Biotech, INC. | $32.30 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyne Pharmaceuticals INC. | $31.86 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.12 | 2021 | |
| Taro Pharmaceuticals USA, INC. | $18.33 | 2019 | |
| Mission Pharmacal Company | $17.07 | 2022 | |
| Celgene Corporation | $17.02 | 2019 | |
| Almirall LLC | $14.85 | 2019 | |
| Epi Health, LLC | $14.10 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Pidkowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.